1. Home
  2. Browse Decisions
  3. F.3d
  4. 916 F.3d
  5. 916 F.3d 975 (2019)
 

DR. FALK PHARMA GMBH v. GENERICO, LLC

2017-2312 2017-2636, 2018-1320 2018-2097.

916 F.3d 975 (2019)

DR. FALK PHARMA GMBH, Appellant and Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Intervenors v. GENERICO, LLC, Flat Line Capital LLC, Mylan Pharmaceuticals Inc., Appellees. Salix Pharmaceuticals, Inc., Dr. Falk Pharma GmbH, Plaintiffs-Appellants v. Mylan Pharmaceuticals Inc., Mylan Inc., Defendants-Appellees. Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc., Wyeth LLC, FKA Wyeth, Plaintiffs-Appellees v. Mylan Pharmaceuticals Inc., Mylan Inc., Mylan Laboratories Limited, Defendants-Appellants. Actavis LLC, Defendant.

United States Court of Appeals, Federal Circuit.

Public Order Filed: February 20, 2019.

Attorney(s) appearing for the Case

Mary W. Bourke , Womble Bond Dickinson (US) LLP, Wilmington, DE, argued for appellant and intervenors in 17-2312 and plaintiffs-appellants in 17-2636. Also represented by Kristen Healey Cramer , Dana Kathryn Severance , Daniel M. Attaway ; John W. Cox , Atlanta, GA.

Charles E. Lipsey , Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Reston, VA, argued for plaintiffs-appellees Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc. in 18-2097. Also represented by Bryan Diner , Justin James Hasford , Esther Lim , Kristi L. McIntyre , Washington, DC; Jessica C. Lebeis , Boston, MA.

Michael Isidoro Verde , Katten Muchin Rosenman LLP, New York, NY, argued for appellee Mylan Pharmaceuticals Inc. in 17-2312, for defendants-appellees in 17-2636, and for defendants-appellants in 18-2097. Also represented by Deepro Mukerjee , Lance Soderstrom , Jonathan Rotenberg , Stephanie Mae Roberts ; Howard Robert Rubin , Rajesh Ram Srinivasan , Eric Thomas Werlinger , Washington, DC; Robert Florence , Sharad Kotagiri Bijanki , Micheal L. Binns , Karen L. Carroll , Parker Poe Adams & Bernstein LLP, Atlanta, GA; Christopher Thomas , Raleigh, NC.

Before Lourie, O'Malley, and Reyna, Circuit Judges.

ON MOTIONS

ORDER

At issue are three motions to disqualify Katten Muchin Rosenman LLP as counsel for Mylan Pharmaceuticals Inc. ("Mylan") in three appeals before this court. Valeant Pharmaceuticals International, Inc. ("Valeant-CA") and Salix Pharmaceuticals, Inc. ("Salix") move to disqualify in Valeant...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases